# Schrodinger, Inc. (SDGR) FY2026 Q2 P&L / Income Statement - Company: Schrodinger, Inc. (SDGR) - Period: 2026-04-01 to 2026-06-30 - Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001490978-26-000068 - Page: https://plicit.ai/financials/sdgr/fy2026-q2-income-statement - Chart image: https://plicit.ai/charts/sdgr-fy2026-q2-income-statement-sankey.png ## Chart details: Revenue by Product and Service Income statement for 2026-04-01 through 2026-06-30. View: Product and service (Schedule of Revenue Recognized from the Sources of Software Products and Services Revenue). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 58,889,000 US dollars - **Total cost of revenues**: 26,457,000 US dollars - **Gross profit**: 32,432,000 US dollars - **Total operating expenses**: 73,979,000 US dollars - **Loss from operations**: negative 41,547,000 US dollars - **Total other income**: 48,894,000 US dollars - **Income (loss) before income taxes**: 7,347,000 US dollars - **Income tax expense**: 1,372,000 US dollars - **Net income (loss)**: 5,975,000 US dollars - **On-premise software**: 9,297,000 US dollars - **Hosted software**: 15,150,000 US dollars - **Software maintenance**: 4,878,000 US dollars - **Professional services**: 3,219,000 US dollars - **Contribution**: 3,359,000 US dollars - **Drug discovery**: 22,986,000 US dollars - **Research and development**: 40,998,000 US dollars - **Sales and marketing**: 10,266,000 US dollars - **General and administrative (includes related party expense of $165, $109, $330 and $218)**: 22,715,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (2) - Page: https://plicit.ai/financials/sdgr/fy2026-q2-income-statement/revenue-by-product-and-service-2 - Chart image: https://plicit.ai/charts/sdgr-fy2026-q2-revenue-by-product-and-service-2-sankey.png Income statement for 2026-04-01 through 2026-06-30. View: Product and service (Schedule of Contribution Revenue). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 58,889,000 US dollars - **Total cost of revenues**: 26,457,000 US dollars - **Gross profit**: 32,432,000 US dollars - **Total operating expenses**: 73,979,000 US dollars - **Loss from operations**: negative 41,547,000 US dollars - **Total other income**: 48,894,000 US dollars - **Income (loss) before income taxes**: 7,347,000 US dollars - **Income tax expense**: 1,372,000 US dollars - **Net income (loss)**: 5,975,000 US dollars - **Software contribution**: 2,921,000 US dollars - **Drug discovery contribution**: 438,000 US dollars - **Contribution**: 3,359,000 US dollars - **Undisclosed (calculated)**: 52,171,000 US dollars - **Research and development**: 40,998,000 US dollars - **Sales and marketing**: 10,266,000 US dollars - **General and administrative (includes related party expense of $165, $109, $330 and $218)**: 22,715,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (3) - Page: https://plicit.ai/financials/sdgr/fy2026-q2-income-statement/revenue-by-product-and-service-3 - Chart image: https://plicit.ai/charts/sdgr-fy2026-q2-revenue-by-product-and-service-3-sankey.png Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue and costs use their disclosed categories. - **Total revenues**: 58,889,000 US dollars - **Total cost of revenues**: 26,457,000 US dollars - **Gross profit**: 32,432,000 US dollars - **Total operating expenses**: 73,979,000 US dollars - **Loss from operations**: negative 41,547,000 US dollars - **Total other income**: 48,894,000 US dollars - **Income (loss) before income taxes**: 7,347,000 US dollars - **Income tax expense**: 1,372,000 US dollars - **Net income (loss)**: 5,975,000 US dollars - **Software products and services revenue**: 32,544,000 US dollars - **Drug discovery revenue**: 22,986,000 US dollars - **Contribution revenue**: 3,359,000 US dollars - **Software products and services cost of revenue**: 9,449,000 US dollars - **Drug discovery cost of revenue**: 15,794,000 US dollars - **Contribution cost of revenue**: 1,214,000 US dollars - **Research and development**: 40,998,000 US dollars - **Sales and marketing**: 10,266,000 US dollars - **General and administrative (includes related party expense of $165, $109, $330 and $218)**: 22,715,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Business Segment - Page: https://plicit.ai/financials/sdgr/fy2026-q2-income-statement/revenue-by-business-segment - Chart image: https://plicit.ai/charts/sdgr-fy2026-q2-revenue-by-business-segment-sankey.png Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue and costs use their disclosed categories. - **Total revenues**: 58,889,000 US dollars - **Total cost of revenues**: 26,457,000 US dollars - **Gross profit**: 32,432,000 US dollars - **Total operating expenses**: 73,979,000 US dollars - **Loss from operations**: negative 41,547,000 US dollars - **Total other income**: 48,894,000 US dollars - **Income (loss) before income taxes**: 7,347,000 US dollars - **Income tax expense**: 1,372,000 US dollars - **Net income (loss)**: 5,975,000 US dollars - **Software revenue**: 35,465,000 US dollars - **Drug Discovery revenue**: 23,424,000 US dollars - **Software cost of revenue**: 10,538,000 US dollars - **Drug Discovery cost of revenue**: 15,919,000 US dollars - **Research and development**: 40,998,000 US dollars - **Sales and marketing**: 10,266,000 US dollars - **General and administrative (includes related party expense of $165, $109, $330 and $218)**: 22,715,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/sdgr/fy2026-q2-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/sdgr-fy2026-q2-revenue-by-geography-sankey.png Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 58,889,000 US dollars - **Total cost of revenues**: 26,457,000 US dollars - **Gross profit**: 32,432,000 US dollars - **Total operating expenses**: 73,979,000 US dollars - **Loss from operations**: negative 41,547,000 US dollars - **Total other income**: 48,894,000 US dollars - **Income (loss) before income taxes**: 7,347,000 US dollars - **Income tax expense**: 1,372,000 US dollars - **Net income (loss)**: 5,975,000 US dollars - **UNITED STATES**: 37,526,000 US dollars - **EMEA**: 14,378,000 US dollars - **APAC**: 6,700,000 US dollars - **Rest of World**: 285,000 US dollars - **Research and development**: 40,998,000 US dollars - **Sales and marketing**: 10,266,000 US dollars - **General and administrative (includes related party expense of $165, $109, $330 and $218)**: 22,715,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.